Exhibit 99.2

EMDEON CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)

	Three Months Ended					Years Ended
	December 31,					December 31,
	2005			2004		2005			2004
Revenue	$	327,236		$	307,641	$	1,276,879		$	1,160,351
Costs and expenses:
Cost of operations		180,024			171,257		717,047			666,431
Development and engineering		14,716			15,682		58,494			54,161
Sales, marketing, general and administrative		85,270			78,973		333,288			324,027
Depreciation and amortization		18,827			16,843		71,767			57,765
Legal expense		3,488			2,653		17,835			9,230
Restructuring and integration charge		—			—		—			4,535
Loss (gain) on investments		2,723			—		6,365			(457	)
Interest income		8,149			4,211		21,531			18,717
Interest expense		4,652			4,824		16,324			19,253
Other expense (income), net		—			—		3,765			(121	)
Income before income tax (benefit) provision and minority interest		25,685			21,620		73,525			44,244
Income tax (benefit) provision		(8,037	)		1,931		(357	)		4,910
Minority interest in WebMD Health Corp., net of tax		870			—		908			—
Net income	$	32,852		$	19,689	$	72,974		$	39,334
Net income per common share:
Basic and diluted	$	0.09		$	0.06	$	0.21		$	0.12
Weighted-average shares outstanding used in computing net income per common share:
Basic		348,261			312,745		341,747			320,080
Diluted		355,782			333,576		352,852			333,343

EMDEON CORPORATION
CONSOLIDATED SEGMENT INFORMATION
(In thousands, except per share data, unaudited)

	Three Months Ended						Years Ended
	December 31,						December 31,
	2005			2004			2005			2004
Revenues
Emdeon Business Services	$	191,102		$	182,126		$	758,851		$	686,585
Emdeon Practice Services		77,062			76,412			304,175			296,115
WebMD		49,104			39,139			168,238			134,317
Porex		18,461			18,556			79,124			77,099
Inter-segment eliminations		(8,493	)		(8,592	)		(33,509	)		(33,765	)
	$	327,236		$	307,641		$	1,276,879		$	1,160,351
Earnings before restructuring, interest, taxes, non-cash and other items (“Adjusted EBITDA”)
Emdeon Business Services	$	39,913		$	41,320		$	154,512		$	131,834
Emdeon Practice Services		9,166			5,555			29,378			14,533
WebMD (a)		12,446			8,735			27,546			26,307
Porex		4,678			5,510			22,524			22,650
Corporate (a)		(13,854	)		(13,724	)		(50,301	)		(51,791	)
	$	52,349		$	47,396		$	183,659		$	143,533
Adjusted EBITDA per basic common share (b)	$	0.15		$	0.15		$	0.54		$	0.45
Adjusted EBITDA per diluted common share (b)	$	0.15		$	0.14		$	0.52		$	0.43
Restructuring, interest, taxes, non-cash and other items (c)
Depreciation and amortization	$	(18,827	)	$	(16,843	)	$	(71,767	)	$	(57,765	)
Amortization of non-cash advertising and distribution services		(3,871	)		(3,933	)		(10,870	)		(18,826	)
Non-cash stock-based compensation		(1,252	)		(1,734	)		(4,739	)		(8,975	)
Legal expense		(3,488	)		(2,653	)		(17,835	)		(9,230	)
(Loss) gain on investments		(2,723	)		—			(6,365	)		457
Restructuring and integration charge		—			—			—			(4,535	)
Interest income		8,149			4,211			21,531			18,717
Interest expense		(4,652	)		(4,824	)		(16,324	)		(19,253	)
Other (expense) income, net		—			—			(3,765	)		121
Minority interest in WebMD Health Corp., net of tax		(870	)		—			(908	)		—
Income tax benefit (provision)		8,037			(1,931	)		357			(4,910	)
Net income	$	32,852		$	19,689		$	72,974		$	39,334
Net income per common share:
Basic and diluted	$	0.09		$	0.06		$	0.21		$	0.12
Weighted-average shares outstanding used in computing net income per common share:
Basic		348,261			312,745			341,747			320,080
Diluted		355,782			333,576			352,852			333,343

(a)	Adjusted EBITDA during prior periods, for the Corporate and WebMD segments, has been reclassified to conform to the current period presentation.
(b)	Adjusted EBITDA per basic and diluted common share is based on the weighted-average shares outstanding used in computing net income per common share (basic and diluted).
(c)	Reconciliation of Adjusted EBITDA to net income.

EMDEON CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)

	December 31,		December 31,
	2005		2004
	(Unaudited)
Assets
Cash and cash equivalents	$	159,510	$	46,019
Short-term investments		267,387		61,675
Accounts receivable, net		233,070		204,447
Inventory		14,251		14,367
Prepaid expenses and other current assets		34,615		40,224
Total current assets		708,833		366,732
Marketable debt securities		—		511,864
Marketable equity securities		4,481		4,017
Property and equipment, net		116,032		89,677
Goodwill		1,075,549		1,010,564
Intangible assets, net		240,510		260,509
Other assets		50,278		48,871
Total Assets	$	2,195,683	$	2,292,234
Liabilities and Stockholders’ Equity
Accounts payable	$	11,611	$	17,366
Accrued expenses		186,381		198,311
Deferred revenue		115,840		99,543
Total current liabilities		313,832		315,220
Convertible notes		650,000		649,999
Other long-term liabilities		15,353		4,500
Minority interest in WebMD Health Corp.		43,229		—
Convertible redeemable exchangeable preferred stock		98,533		98,299
Stockholders’ equity		1,074,736		1,224,216
Total Liabilities and Stockholders’ Equity	$	2,195,683	$	2,292,234

EMDEON CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)

	Years Ended
	December 31,
	2005			2004
Cash flows from operating activities:
Net income	$	72,974		$	39,334
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		71,767			57,765
Minority interest in WebMD Health Corp., net of tax		908			—
Amortization of debt issuance costs		2,541			2,975
Non-cash advertising and distribution services		10,870			18,826
Non-cash stock-based compensation		4,739			8,975
Bad debt expense		6,410			3,606
Loss (gain) on investments		6,365			(457	)
Gain on sale of property and equipment		—			(121	)
Loss on redemption of convertible debt		1,902			—
Non-cash reversal of income tax valuation allowance		444			—
Changes in operating assets and liabilities:
Accounts receivable		(30,613	)		(16,152	)
Inventory		(224	)		(1,077	)
Prepaid expenses and other, net		2,683			3,514
Accounts payable		(6,074	)		5,577
Accrued expenses and other long-term liabilities		7,526			(43,703	)
Deferred revenue		9,068			10,982
Net cash provided by operating activities		161,286			90,044
Cash flows from investing activities:
Proceeds from maturities and sales of available-for-sale securities		1,063,606			1,408,091
Purchases of available-for-sale securities		(758,687	)		(1,308,303	)
Purchases of property and equipment		(62,645	)		(38,800	)
Proceeds received from sale of property and equipment		400			417
Cash paid in business combinations, net of cash acquired		(93,742	)		(249,557	)
Net cash provided by (used in) investing activities		148,932			(188,152	)
Cash flows from financing activities:
Proceeds from issuance of common stock		48,571			38,052
Purchases of treasury stock under repurchase program		(21,246	)		(32,110	)
Purchases of treasury stock in Tender Offer		(549,268	)		—
Net proceeds from issuance of convertible debt		289,875			—
Issuance of WebMD Health Corp. Class A common stock		123,344			—
Net proceeds from issuance of preferred shares		—			98,115
Redemption of convertible debt		(86,694	)		—
Payments of notes payable and other		(631	)		(602	)
Net cash (used in) provided by financing activities		(196,049	)		103,455
Effect of exchange rates on cash		(678	)		1,024
Net increase in cash and cash equivalents		113,491			6,371
Cash and cash equivalents at beginning of period		46,019			39,648
Cash and cash equivalents at end of period	$	159,510		$	46,019